BMS-1166-N-piperidine-CO-N-piperazine dihydrochloride

Modify Date: 2025-08-28 19:42:24

BMS-1166-N-piperidine-CO-N-piperazine dihydrochloride Structure
BMS-1166-N-piperidine-CO-N-piperazine dihydrochloride structure
Common Name BMS-1166-N-piperidine-CO-N-piperazine dihydrochloride
CAS Number 2691796-83-3 Molecular Weight 780.18
Density N/A Boiling Point N/A
Molecular Formula C41H45Cl3N4O5 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of BMS-1166-N-piperidine-CO-N-piperazine dihydrochloride


BMS-1166-N-piperidine-CO-N-piperazine dihydrochloride incorporates a ligand for PD-1/PD-L1 immune checkpoint, and a PROTAC linker. BMS-1166-N-piperidine-CO-N-piperazine dihydrochloride can be used in the synthesis of PD-1/PD-L1 degrader-1.html" class="link-product" target="_blank">PROTAC PD-1/PD-L1 degrader-1 (HY-131183). PROTAC PD-1/PD-L1 degrader-1 inhibits PD-1/PD-L1 interaction with an IC50 of 39.2 nM[1].

 Names

Name BMS-1166-N-piperidine-CO-N-piperazine dihydrochloride

  Biological Activity

Description BMS-1166-N-piperidine-CO-N-piperazine dihydrochloride incorporates a ligand for PD-1/PD-L1 immune checkpoint, and a PROTAC linker. BMS-1166-N-piperidine-CO-N-piperazine dihydrochloride can be used in the synthesis of PD-1/PD-L1 degrader-1.html" class="link-product" target="_blank">PROTAC PD-1/PD-L1 degrader-1 (HY-131183). PROTAC PD-1/PD-L1 degrader-1 inhibits PD-1/PD-L1 interaction with an IC50 of 39.2 nM[1].
Related Catalog
In Vitro PROTAC 包含两个不同的配体,通过一个接头连接;一个是 E3 泛素连接酶的配体,另一个是靶蛋白的配体。PROTAC 利用细胞内泛素-蛋白酶体系统选择性降解靶蛋白[1]。
References

[1]. Cheng B, Ren Y, Cao H, Chen J. Discovery of novel resorcinol diphenyl ether-based PROTAC-like molecules as dual inhibitors and degraders of PD-L1. Eur J Med Chem. 2020;199:112377.  

 Chemical & Physical Properties

Molecular Formula C41H45Cl3N4O5
Molecular Weight 780.18
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here
Related Compounds: More...
[8-(Hydroxy-kappaO)-7-[2-[2-(hydroxy-kappaO)-5-hydroxy-7-sulfo-6-[2-[4-[(2,5,6-trichloro-4-pyrimidinyl)amino]phenyl]diazenyl]-1-naphthalenyl]diazenyl-kappaN1]-1,3,5-naphthalenetrisulfonato(6-)]-cuprate(4-) sodium (1:4)
141048-13-7
Calcium, 6-((3-carboxylatopropanoyl)amino)-2-((3-carboxypropanoyl)amino)hexanoate
1422423-64-0
Antimonate(1-), hexachloro-, hydrogen-d, (OC-6-11)-
51652-54-1
(3R)-2-[[(5R)-3-amino-5-hydroxy-5-(hydroxymethyl)-2-methoxycyclohex-2-en-1-ylidene]amino]-3-hydroxybutanoic acid
1179319-25-5
rel-4-[(1R,3S)-1-Ethyl-1,3-dimethylpentyl]phenol
1366228-79-6
Iron(1+), chloro[rel-dimethyl (1R,2S,4R,5S)-9,9-dihydroxy-3-methyl-2,4-di(2-pyridinyl-kappaN)-7-[(2-pyridinyl-kappaN)methyl]-3,7-diazabicyclo[3.3.1]nonane-1,5-dicarboxylate-kappaN3,kappaN7]-, (OC-6-52)-
736923-31-2
[(3R,4R,5R,6R)-6-[[(2S,3aS,6R,7aS)-2-[2-(1-carbamimidoyl-2,5-dihydropyrrol-3-yl)ethylcarbamoyl]-1-[(3R)-3-chloro-2-[[(2R)-2-hydroxy-3-phenylpropanoyl]amino]-4-methylpentanoyl]-2,3,3a,4,5,6,7,7a-octahydroindol-6-yl]oxy]-4,5-dihydroxyoxan-3-yl] hydrogen sulfate
1963001-83-3
[(2R,3aS,6R,7aS)-1-[(3S)-2-[[(2R)-3-(3-bromo-4-hydroxyphenyl)-2-hydroxypropanoyl]amino]-3-methylpentanoyl]-2-[4-(diaminomethylideneamino)butylcarbamoyl]-2,3,3a,4,5,6,7,7a-octahydroindol-6-yl] hydrogen sulfate
167172-73-8
Ferrate(2-), [N-[2-[bis[(carboxy-I masculineO)methyl]amino-I masculineN]ethyl]-N-[2-[[(carboxy-I masculineO)methyl](carboxymethyl)amino-I masculineN]ethyl]glycinato(5-)-I masculineN,I masculineO]-, potassium hydrogen (1:1:1)
2055396-18-2
Cuprate(4-), [mu-[[3,3a(2)-[[3,3a(2)-di(hydroxy-kappaO)[1,1a(2)-biphenyl]-4,4a(2)-diyl]bis(2,1-diazenediyl-kappaN1)]bis[5-amino-4-(hydroxy-kappaO)-2,7-naphthalenedisulfonato]](8-)]]di-, sodium hydrogen (1:2:2)
1254333-41-9